Twist Bioscience executive plans $79.8k stock sale per Form 144

Rhea-AI Filing Summary

Twist Bioscience Corp. (TWST) – Form 144 filing discloses that insider Patrick Finn plans to sell 2,232 common shares through Fidelity Brokerage on or about 23 Jul 2025. At the stated market value of $79,773, the proposed sale equals roughly 0.004% of the company’s 59.9 million shares outstanding.

The notice also lists five prior sales by Finn during the last three months, totaling 26,944 shares and $897,390 in gross proceeds (dates: 23 Apr, 5 May, 8 May, 21 May, 2 Jul 2025). The shares were acquired via restricted-stock vesting on 22 Jul 2025, indicating compensation-related disposal rather than open-market buying and selling. By signing Form 144, the filer attests to possessing no undisclosed adverse information.

Though the absolute size is small, the continued disposition may signal a modestly negative insider sentiment trend that investors could monitor.

Positive

• None.

Negative

• Series of insider sales—26,944 shares in prior 3 months plus 2,232 shares planned—may signal reduced insider confidence.
• Continuous disposition trend could be viewed negatively by investors tracking executive alignment, despite small relative size.

Insights

Financial Analyst

TL;DR: Routine, immaterial insider sale; limited direct valuation impact.

The 2,232-share Form 144 equals just 0.004 % of outstanding stock and follows recent vesting. Aggregate insider disposals (~27 k shares) remain negligible versus float, suggesting minimal near-term price pressure. However, repetitive sales could influence perception if pattern persists. On fundamentals, filing offers no new financial data; therefore, impact on earnings outlook is neutral.

Corporate Governance Expert

TL;DR: Continuous insider selling may raise modest governance red flag.

While statutory and properly disclosed, Patrick Finn’s successive Form 144 sales within a three-month window illustrate ongoing liquidity events by a key executive. Frequent divestitures—totaling almost $1 m since April—can be interpreted as waning long-term alignment, especially absent offsetting insider purchases. Still, size is too small to threaten control or voting dynamics. Overall governance impact: mildly negative.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/23/2025 - 03:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2232	79773.02	59916141	07/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/22/2025	Restricted Stock Vesting	Issuer			2232	07/22/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Patrick Finn 681 Gateway Blvd. South San Francisco CA 94080	Common	04/23/2025	2058	82310.53
Patrick Finn 681 Gateway Blvd. South San Francisco CA 94080	Common	05/05/2025	2800	105422.80
Patrick Finn 681 Gateway Blvd. South San Francisco CA 94080	Common	05/08/2025	20000	646256.55
Patrick Finn 681 Gateway Blvd. South San Francisco CA 94080	Common	05/21/2025	1877	55835.87
Patrick Finn 681 Gateway Blvd. South San Francisco CA 94080	Common	07/02/2025	209	7564.36

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Twist Bioscience (TWST) shares does Patrick Finn intend to sell?

The Form 144 covers 2,232 common shares valued at about $79,773.

When is the planned sale date for the TWST shares?

The approximate sale date listed is 23 July 2025.

What percentage of outstanding TWST shares does the sale represent?

Around 0.004% of the 59,916,141 shares outstanding.

How much has Patrick Finn already sold in the past three months?

He sold 26,944 shares for gross proceeds of $897,390 between April and July 2025.

Were the shares being sold recently purchased or vested?

They were acquired via restricted-stock vesting on 22 Jul 2025, categorized as compensation.

Does the filing provide any new financial performance data for TWST?

No. Form 144 only details proposed insider sales and contains no earnings or revenue information.